Prenetics Global Limited (PRE), a health sciences company, has undergone a significant rebuilding phase in recent years and anticipates 2025 to be a pivotal year in its continued transformation.
The company operates across three strategic segments, namely: Consumer Health, Prevention, and Diagnostics, each operated through dedicated business units.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com